Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,002 public trials 2,553 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

NCT07318558

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Mount Sinai Cancer Center ( Site 0029) Miami Beach, Florida, United States
  • Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085) Orlando, Florida, United States
  • Winship Cancer Institute of Emory University ( Site 0037) Atlanta, Georgia, United States
  • Illinois Cancer Specialists (ICS) ( Site 8009) Arlington Heights, Illinois, United States
View all 163 locations
View Trial Details
Recruiting

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

NCT04038502

Conditions
BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +23 more
Locations
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States
  • Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora, Colorado, United States
  • Washington DC VA Medical Center, Washington, DC Washington D.C., District of Columbia, United States
  • Bay Pines VA Healthcare System, Pay Pines, FL Bay Pines, Florida, United States
View all 18 locations
View Trial Details
Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

NCT05256225

Conditions
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 414 locations
View Trial Details
Recruiting

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

NCT06925737

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Mayo Clinic in Arizona - Phoenix ( Site 0044) Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center ( Site 0049) Duarte, California, United States
  • City of Hope Lennar Foundation Cancer Center ( Site 0059) Irvine, California, United States
  • Moores Cancer Center ( Site 0010) La Jolla, California, United States
View all 298 locations
View Trial Details
Recruiting

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

NCT05011383

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora, Colorado, United States
  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT West Haven, Connecticut, United States
  • North Florida/South Georgia Veterans Health System, Gainesville, FL Gainesville, Florida, United States
  • Orlando VA Medical Center, Orlando, FL Orlando, Florida, United States
View all 17 locations
View Trial Details
Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

NCT05112601

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University Cancer and Blood Center LLC Athens, Georgia, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • Saint Alphonsus Cancer Care Center-Boise Boise, Idaho, United States
View all 138 locations
View Trial Details
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

NCT07216703

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Florida Cancer Specialists - South ( Site 7001) Fort Myers, Florida, United States
  • Mount Sinai Comprehensive Cancer Center ( Site 6000) Miami Beach, Florida, United States
  • Florida Cancer Specialists - East ( Site 7000) West Palm Beach, Florida, United States
  • Winship Cancer Institute of Emory University ( Site 5005) Atlanta, Georgia, United States
View all 174 locations
View Trial Details
Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT05564377

Conditions
Adnexal Diseases, Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, +36 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 482 locations
View Trial Details

Related conditions